These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9457156)

  • 1. Obesity.
    Aronne LJ
    Med Clin North Am; 1998 Jan; 82(1):161-81. PubMed ID: 9457156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fenfluramine/phentermine combination for weight loss.
    Garrett SD; Cupp MJ
    Nurse Pract; 1997 Aug; 22(8):166, 168, 170. PubMed ID: 9279853
    [No Abstract]   [Full Text] [Related]  

  • 3. Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine.
    Hensrud DD; Connolly HM; Grogan M; Miller FA; Bailey KR; Jensen MD
    Mayo Clin Proc; 1999 Dec; 74(12):1191-7. PubMed ID: 10593346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacologic management of obesity.
    Cerda JJ
    J Fla Med Assoc; 1997 Feb; 84(2):89-92. PubMed ID: 9066231
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term drug treatment of obesity in a private practice setting.
    Atkinson RL; Blank RC; Schumacher D; Dhurandhar NV; Ritch DL
    Obes Res; 1997 Nov; 5(6):578-86. PubMed ID: 9449143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of obesity].
    Wechsler JG
    Internist (Berl); 1995 Nov; 36(11):1063-9. PubMed ID: 8543442
    [No Abstract]   [Full Text] [Related]  

  • 7. Why the attitude?
    McPhilomy E
    JAAPA; 2009 Mar; 22(3):45. PubMed ID: 19354115
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation and treatment of obesity.
    Azar ST; Zantout MS
    J Med Liban; 2000; 48(5):310-4. PubMed ID: 12489585
    [No Abstract]   [Full Text] [Related]  

  • 9. A dangerous duo? A combination of common diet drugs (fen-phen) may lead to heart valve disease.
    Boughner DR
    CMAJ; 1997 Sep; 157(6):705-6. PubMed ID: 9307558
    [No Abstract]   [Full Text] [Related]  

  • 10. The fen-phen controversy: is regression another piece of the puzzle?
    Asinger RW
    Mayo Clin Proc; 1999 Dec; 74(12):1302-4. PubMed ID: 10593359
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo.
    Weintraub M; Sundaresan PR; Madan M; Schuster B; Balder A; Lasagna L; Cox C
    Clin Pharmacol Ther; 1992 May; 51(5):586-94. PubMed ID: 1587072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose effect of fenfluramine-phentermine in the production of valvular heart disease.
    Tovar EA; Landa DW; Borsari BE
    Ann Thorac Surg; 1999 Apr; 67(4):1213-4. PubMed ID: 10320298
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of weight loss on blood pressure].
    Bönner G
    MMW Fortschr Med; 2007 Nov; 149(48):44-7; quiz 48. PubMed ID: 18161437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of profound weight loss secondary to use of phentermine.
    Uwaifo GI; Melcescu E; McDonald A; Koch CA
    J Miss State Med Assoc; 2009 Dec; 50(12):407-15. PubMed ID: 20806811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a meal replacement system alone or in combination with phentermine on weight loss and food cravings.
    Moldovan CP; Weldon AJ; Daher NS; Schneider LE; Bellinger DL; Berk LS; Hermé AC; Aréchiga AL; Davis WL; Peters WR
    Obesity (Silver Spring); 2016 Nov; 24(11):2344-2350. PubMed ID: 27664021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appetite suppressants as adjuncts for weight loss.
    Wilbert B; Mohundro BL; Shaw V; Andres A
    Am Fam Physician; 2011 Apr; 83(7):1-2. PubMed ID: 21674993
    [No Abstract]   [Full Text] [Related]  

  • 17. Autopsy findings of heart and lungs in a patient with primary pulmonary hypertension associated with use of fenfluramine and phentermine.
    Tomita T; Zhao Q
    Chest; 2002 Feb; 121(2):649-52. PubMed ID: 11834685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine.
    Jones KL; Johnson KA; Dick LM; Felix RJ; Kao KK; Chambers CD
    Teratology; 2002 Mar; 65(3):125-30. PubMed ID: 11877776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term weight control study. II (weeks 34 to 104). An open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise.
    Weintraub M; Sundaresan PR; Schuster B; Ginsberg G; Madan M; Balder A; Stein EC; Byrne L
    Clin Pharmacol Ther; 1992 May; 51(5):595-601. PubMed ID: 1587073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative trial of different regimens of fenfluramine and phentermine in obesity.
    Steel JM; Munro JF; Duncan LJ
    Practitioner; 1973 Aug; 211(262):232-6. PubMed ID: 4580610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.